These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16518815)

  • 1. Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma.
    Kasperts N; Slotman BJ; Leemans CR; de Bree R; Doornaert P; Langendijk JA
    Cancer; 2006 Apr; 106(7):1536-47. PubMed ID: 16518815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II study of primary reirradiation in squamous cell carcinoma of head and neck.
    Langendijk JA; Kasperts N; Leemans CR; Doornaert P; Slotman BJ
    Radiother Oncol; 2006 Mar; 78(3):306-12. PubMed ID: 16524634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Initial results of a Phase I/II reirradiation study.
    Martínez-Monge R; Alcalde J; Concejo C; Cambeiro M; Garrán C
    Brachytherapy; 2006; 5(1):32-40. PubMed ID: 16563995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
    Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
    Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review on re-irradiation for recurrent and second primary head and neck cancer.
    Kasperts N; Slotman B; Leemans CR; Langendijk JA
    Oral Oncol; 2005 Mar; 41(3):225-43. PubMed ID: 15743686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
    Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
    Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR
    Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR brachytherapy.
    Kolotas C; Tselis N; Sommerlad M; Röddiger S; Schnabel T; Baltas D; Kalogera-Fountzila A; Fountzilas G; Zamboglou N
    Strahlenther Onkol; 2007 Feb; 183(2):69-75. PubMed ID: 17294110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid carcinoma: is there a role for adjuvant radiation therapy?
    Munson ND; Foote RL; Northcutt RC; Tiegs RD; Fitzpatrick LA; Grant CS; van Heerden JA; Thompson GB; Lloyd RV
    Cancer; 2003 Dec; 98(11):2378-84. PubMed ID: 14635072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reirradiation after salvage surgery and microvascular free flap reconstruction for recurrent head and neck carcinoma.
    Suh JD; Kim BP; Abemayor E; Sercarz JA; Nabili V; Liu JH; Juillard GJ; Blackwell KE
    Otolaryngol Head Neck Surg; 2008 Dec; 139(6):781-6. PubMed ID: 19041503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer.
    Glatzel M; Büntzel J; Schröder D; Küttner K; Fröhlich D
    Laryngoscope; 2002 Aug; 112(8 Pt 1):1366-71. PubMed ID: 12172246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage re-irradiation for recurrent head and neck cancer.
    Lee N; Chan K; Bekelman JE; Zhung J; Mechalakos J; Narayana A; Wolden S; Venkatraman ES; Pfister D; Kraus D; Shah J; Zelefsky MJ
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):731-40. PubMed ID: 17379449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reirradiation for head-and-neck cancer: delicate balance between effectiveness and toxicity.
    Hoebers F; Heemsbergen W; Moor S; Lopez M; Klop M; Tesselaar M; Rasch C
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e111-8. PubMed ID: 21362581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative radiotherapy for insecure or positive surgical margins in head and neck cancer.
    Ampil FL; Caldito G; Ghali GE; Nathan CO
    J Oral Maxillofac Surg; 2003 Apr; 61(4):425-9. PubMed ID: 12684958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911.
    Langer CJ; Harris J; Horwitz EM; Nicolaou N; Kies M; Curran W; Wong S; Ang K
    J Clin Oncol; 2007 Oct; 25(30):4800-5. PubMed ID: 17947728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers.
    Watkins JM; Shirai KS; Wahlquist AE; Stuart RK; Chaudhary UB; Garrett-Mayer E; Day TA; Gillespie MB; Sharma AK
    Head Neck; 2009 Apr; 31(4):493-502. PubMed ID: 19156831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck.
    Spencer SA; Harris J; Wheeler RH; Machtay M; Schultz C; Spanos W; Rotman M; Meredith R; Ang KK
    Head Neck; 2008 Mar; 30(3):281-8. PubMed ID: 17764087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
    Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
    Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
    Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
    BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative concurrent chemoradiotherapy with mitomycin in advanced squamous cell carcinoma of the head and neck: results from three prospective randomized trials.
    Rewari AN; Haffty BG; Wilson LD; Son YH; Joe JK; Ross DA; Papac RJ; Sasaki CT; Fischer JJ
    Cancer J; 2006; 12(2):123-9. PubMed ID: 16630403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.